Neglected aspect of the strategy for human breast diseases: trans-areolar drug delivery

Related Experiment Video

Updated: May 28, 2026

Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models
13:43

Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models

Published on: April 1, 2022

Chao Shao1, Aidong Li, Jian Zhang

  • 1Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.

Medical Hypotheses
|October 8, 2011
PubMed

Insights

The human breast areola

Area of Science:

  • Evolutionary biology
  • Phylogeny
  • Dermatology

Background:

  • Breast cancer is a leading global health concern for women.
  • Current breast disease treatments focus on oncoplastic surgery and reconstruction.
  • Novel therapeutic strategies for breast diseases are essential.

Purpose of the Study:

  • To investigate the evolutionary history and phylogenetic origins of the human breast areola.
  • To explore the unique anatomical and physiological characteristics of the areola.
  • To assess the potential of the areola for enhancing transdermal drug delivery for breast conditions.

Main Methods:

  • Phylogenetic analysis of the human breast areola.
  • Histological examination of areolar skin appendages and glands.
  • Assessment of dermal microvascular characteristics and drug penetration potential.

Main Results:

  • The human breast areola exhibits a unique evolutionary and phylogenetic history.
  • Areolar skin possesses diverse glands (e.g., Montgomery's glands) and hair follicles.
  • These features create a "sink" phenomenon, facilitating deeper drug penetration and increasing delivery area.

Conclusions:

  • The human breast areola's unique structure enhances transdermal drug delivery.
  • This finding offers potential for new therapeutic and prophylactic strategies for breast diseases.
  • Further research into areolar drug delivery could optimize breast cancer treatment and prevention.

More Related Videos

Intraductal Delivery to the Rabbit Mammary Gland06:30

Intraductal Delivery to the Rabbit Mammary Gland

Published on: March 9, 2017

Related Concept Videos

Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...